Myeloid Blood Cancer Treatment Market Analysis

The myeloid blood cancer treatment market is segmented on the basis of treatment type into chemotherapy, immunotherapy, radiotherapy, targeted therapy, stem cell therapy, and others, out of which, the targeted therapy segment is anticipated to grab the largest share by the end of 2021 on account of higher positive diagnosis rates and better efficiency of targeted therapy than chemotherapy. Moreover, immunotherapy is also widely being used for the treatment of myeloid blood cancer, which is also projected to contribute to the growth of the market during the forecast period.

On the basis of end-user, the specialty hospitals segment in the global myeloid blood cancer treatment market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that myeloid blood cancer is a relatively rare occurrence and as a result, a considerable portion of the population with this cancer on a global level tend to choose healthcare facilities specializing in its treatment.

Our in-depth analysis of the global market includes the following segments